FBT Top Holdings & Constituents
FBT, offered by First Trust, holds 32 reported positions across $2.8B in assets. Its largest holdings are Moderna Inc (MRNA) (5.26%), United Therapeutics Corporation (UTHR) (4.36%), and Alkermes PLC (ALKS) (4.24%). The 5 biggest positions account for 21.83% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
MRNA Moderna Inc | 5.26% | $119.45M |
UTHR United Therapeutics Corporation | 4.36% | $98.94M |
ALKS Alkermes PLC | 4.24% | $96.15M |
GILD Gilead Sciences Inc. | 4.09% | $92.82M |
AXSM Axsome Therapeutics Inc. | 3.89% | $88.21M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Mar 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.